Walleye Capital’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3K | Sell |
1,633
-33,866
| -95% | -$897K | ﹤0.01% | 1661 |
|
|
2025
Q1 | $857K | Buy |
35,499
+34,799
| +4,971% | +$840K | ﹤0.01% | 894 |
|
|
2024
Q4 | $28.2K | Sell |
700
-7,139
| -91% | -$287K | ﹤0.01% | 1822 |
|
|
2024
Q3 | $496K | Buy |
7,839
+1,655
| +27% | +$105K | ﹤0.01% | 1342 |
|
|
2024
Q2 | $328K | Sell |
6,184
-10,016
| -62% | -$531K | ﹤0.01% | 1658 |
|
|
2024
Q1 | $1.33M | Buy |
+16,200
| New | +$1.33M | ﹤0.01% | 921 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3037 |
|
|
2023
Q3 | – | Sell |
-81,251
| Closed | -$1.32M | – | 3013 |
|
|
2023
Q2 | $1.32M | Buy |
81,251
+38,187
| +89% | +$619K | ﹤0.01% | 648 |
|
|
2023
Q1 | $717K | Sell |
43,064
-170,247
| -80% | -$2.83M | 0.01% | 848 |
|
|
2022
Q4 | $2.01M | Sell |
213,311
-885,019
| -81% | -$8.32M | 0.04% | 471 |
|
|
2022
Q3 | $2.99M | Buy |
1,098,330
+802,330
| +271% | +$2.18M | 0.06% | 322 |
|
|
2022
Q2 | $855K | Buy |
296,000
+218,982
| +284% | +$633K | 0.02% | 712 |
|
|
2022
Q1 | $231K | Buy |
+77,018
| New | +$231K | 0.01% | 1397 |
|
|
2020
Q1 | – | Sell |
-22,736
| Closed | -$182K | – | 969 |
|
|
2019
Q4 | $182K | Buy |
+22,736
| New | +$182K | 0.01% | 377 |
|
|
2018
Q3 | $306K | Buy |
+17,574
| New | +$306K | 0.14% | 159 |
|